ClinVar Miner

Submissions for variant NM_022132.5(MCCC2):c.1300G>C (p.Val434Leu)

gnomAD frequency: 0.00001  dbSNP: rs758506791
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001339747 SCV001533515 uncertain significance 3-methylcrotonyl-CoA carboxylase 2 deficiency 2022-09-18 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 434 of the MCCC2 protein (p.Val434Leu). This variant is present in population databases (rs758506791, gnomAD 0.003%). This missense change has been observed in individual(s) with 3MCC deficiency (PMID: 22642865). ClinVar contains an entry for this variant (Variation ID: 1036699). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MCCC2 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on MCCC2 function (PMID: 22642865). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
CeGaT Center for Human Genetics Tuebingen RCV002292631 SCV002586056 likely pathogenic not provided 2022-08-01 criteria provided, single submitter clinical testing MCCC2: PM2, PM3, PP4, PS3:Supporting
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002509666 SCV002819590 likely pathogenic Methylcrotonyl-CoA carboxylase deficiency 2022-12-15 criteria provided, single submitter clinical testing Variant summary: MCCC2 c.1300G>C (p.Val434Leu) results in a conservative amino acid change located in the Acetyl-coenzyme A carboxyltransferase, C-terminal domain (IPR011763) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251484 control chromosomes (gnomAD). c.1300G>C has been reported in the literature in homozygous individuals affected with Methylcrotonyl-CoA Carboxylase Deficiency (Grunert_2012, Navarrete_2019). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, demonstrating that the variant severely reduced protein expression. However, the resulting protein retained most of its enzymatic activity (73.7-77% residual activity, Grunert_2012). Three ClinVar submitters have assessed the variant since 2014: two classified the variant as uncertain significance and one as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Natera, Inc. RCV001339747 SCV002084920 uncertain significance 3-methylcrotonyl-CoA carboxylase 2 deficiency 2020-02-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.